Home › Niet-kleincellige longkanker › Montana › Great Falls
Niet-kleincellige longkanker klinische studies in Great Falls, MT
9 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Great Falls (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
RekruterenFase 3
- Benefis Sletten Cancer Institute, Great Falls
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Benefis Sletten Cancer Institute, Great Falls
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruterenFase 3
- Benefis Sletten Cancer Institute, Great Falls
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RekruterenFase 2
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Benefis Sletten Cancer Institute, Great Falls
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Benefis Sletten Cancer Institute, Great Falls
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Benefis Sletten Cancer Institute, Great Falls
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Benefis Sletten Cancer Institute, Great Falls
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Benefis Sletten Cancer Institute, Great Falls
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Andere studies in Great Falls
- Prostaatkanker10 studies
- Longkanker9 studies
- Acute myeloïde leukemie6 studies
- Blasenkanker5 studies
- Borstkanker5 studies
- Plaveiselcelcarcinoom van hoofd en hals5 studies
- Colorectale kanker5 studies
- Melanoom5 studies
- Dikkedarmkanker4 studies
- Endometriumkanker3 studies
- Rectumkanker3 studies
- Chronische lymfatische leukemie3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.